TEVA-SITAGLIPTIN MALATE

Product Overview

About TEVA-SITAGLIPTIN MALATE

TEVA-SITAGLIPTIN MALATE is a prescription medication containing the active ingredient SITAGLIPTIN (SITAGLIPTIN MALATE), a dipeptidyl peptidase-4 (DPP-4) inhibitor. It is used in the treatment of type 2 diabetes mellitus to improve glycemic control.

Key Benefits & Uses

Improves glycemic control in patients with type 2 diabetes mellitus
Helps to lower HbA1c levels and reduce the risk of hypoglycemia when used alone or in combination with other antidiabetic medications
May be used as an adjunct to diet and exercise to improve blood sugar control in patients with type 2 diabetes mellitus

Active Ingredient & Action

SITAGLIPTIN (SITAGLIPTIN MALATE) works by inhibiting the enzyme DPP-4, which is responsible for breaking down incretin hormones. By inhibiting DPP-4, SITAGLIPTIN increases the levels of incretin hormones, leading to increased insulin release and decreased glucagon levels in the circulation. This results in improved glycemic control and reduced glucose production in the liver.

Important Notes

TEVA-SITAGLIPTIN MALATE should be used under the guidance of a healthcare professional. It is essential to follow the recommended dosage and administration instructions carefully. Patients with a history of pancreatitis, kidney disease, or liver disease should be monitored closely while taking TEVA-SITAGLIPTIN MALATE. Common side effects include nausea, vomiting, and diarrhea. Patients should report any adverse reactions to their healthcare provider promptly.